Concepedia

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression

Marion Wobser, Heike Voigt, Roland Houben, Andreas O. Eggert, Matthias Freiwald, Ulrike Kaemmerer, Eckhart Kaempgen, David Schrama, Juergen C. Becker

Cancer Immunology Immunotherapy · 2006 · 76 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism

David H. Munn, Min Zhou, John T. Attwood et al. · Science · 1998 · 2.6K citations

, , +16

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Catherine Uyttenhove, Luc Pilotte, Ivan Théate et al. · Nature Medicine · 2003 · 2.3K citations

, , +11

Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

David H. Munn, Madhav Sharma, Jeffrey R. Lee et al. · Science · 2002 · 1K citations

, , +17

Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells

Peter Terness, Thomas M. Bauer, Lars Röse et al. · The Journal of Experimental Medicine · 2002 · 929 citations · Full text

, , +17

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

David H. Munn, Madhav Sharma, De‐Yan Hou et al. · Journal of Clinical Investigation · 2004 · 846 citations · Full text

, , +15